Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases. This ...
Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...
‘For me, the concern was just how easy it was to do’ ‘For me, the concern was just how easy it was to do’ is a senior science reporter covering energy and the environment with more than a decade of ...